Penning TM - Search Results

1

AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer.

Rizner TL, Smuc T, Rupreht R, Sinkovec J, Penning TM. Rizner TL, et al. Among authors: penning tm. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):126-35. doi: 10.1016/j.mce.2005.10.009. Epub 2005 Dec 9. Mol Cell Endocrinol. 2006. PMID: 16338060

2

Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).

Penning TM, Burczynski ME, Jez JM, Lin HK, Ma H, Moore M, Ratnam K, Palackal N. Penning TM, et al. Mol Cell Endocrinol. 2001 Jan 22;171(1-2):137-49. doi: 10.1016/s0303-7207(00)00426-3. Mol Cell Endocrinol. 2001. PMID: 11165022

3

Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells.

Rizner TL, Lin HK, Penning TM. Rizner TL, et al. Among authors: penning tm. Chem Biol Interact. 2003 Feb 1;143-144:401-9. doi: 10.1016/s0009-2797(02)00179-5. Chem Biol Interact. 2003. PMID: 12604227

4

Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.

Rizner TL, Lin HK, Peehl DM, Steckelbroeck S, Bauman DR, Penning TM. Rizner TL, et al. Among authors: penning tm. Endocrinology. 2003 Jul;144(7):2922-32. doi: 10.1210/en.2002-0032. Endocrinology. 2003. PMID: 12810547

5

Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins.

Penning TM, Jin Y, Steckelbroeck S, Lanisnik Rizner T, Lewis M. Penning TM, et al. Mol Cell Endocrinol. 2004 Feb 27;215(1-2):63-72. doi: 10.1016/j.mce.2003.11.006. Mol Cell Endocrinol. 2004. PMID: 15026176 Review.

6

Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues.

Sharma KK, Lindqvist A, Zhou XJ, Auchus RJ, Penning TM, Andersson S. Sharma KK, et al. Among authors: penning tm. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):79-86. doi: 10.1016/j.mce.2005.10.024. Epub 2005 Dec 5. Mol Cell Endocrinol. 2006. PMID: 16337083

7

Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors.

Penning TM, Steckelbroeck S, Bauman DR, Miller MW, Jin Y, Peehl DM, Fung KM, Lin HK. Penning TM, et al. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):182-91. doi: 10.1016/j.mce.2005.12.009. Epub 2006 Jan 18. Mol Cell Endocrinol. 2006. PMID: 16417966

8

Pre-receptor regulation of the androgen receptor.

Penning TM, Jin Y, Rizner TL, Bauman DR. Penning TM, et al. Mol Cell Endocrinol. 2008 Jan 16;281(1-2):1-8. doi: 10.1016/j.mce.2007.10.008. Epub 2007 Oct 22. Mol Cell Endocrinol. 2008. PMID: 18060684 Free PMC article. Review.

9

Estrogen biosynthesis in human H295 adrenocortical carcinoma cells.

Nicol MR, Papacleovoulou G, Evans DB, Penning TM, Strachan MW, Advani A, Johnson SJ, Quinton R, Mason JI. Nicol MR, et al. Among authors: penning tm. Mol Cell Endocrinol. 2009 Mar 5;300(1-2):115-20. doi: 10.1016/j.mce.2008.10.032. Epub 2008 Nov 5. Mol Cell Endocrinol. 2009. PMID: 19026713 Free PMC article.

10

Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library.

Brožič P, Turk S, Adeniji AO, Konc J, Janežič D, Penning TM, Lanišnik Rižner T, Gobec S. Brožič P, et al. Among authors: penning tm. J Med Chem. 2012 Sep 13;55(17):7417-24. doi: 10.1021/jm300841n. Epub 2012 Aug 27. J Med Chem. 2012. PMID: 22881866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,720 results

Search Page